We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.59B
AUM Growth
+$160M
Cap. Flow
-$54.6M
Cap. Flow %
-3.43%
Top 10 Hldgs %
16.55%
Holding
226
New
31
Increased
63
Reduced
63
Closed
27

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$19M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$16.3M
3
AMRS
Amyris Inc.
AMRS
+$14.3M
4
ESTA icon
Establishment Labs
ESTA
+$12.8M
5
SQSP
Squarespace, Inc.
SQSP
+$9.51M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$20M
2
NVCR icon
NovoCure
NVCR
+$14.8M
3
SEER icon
Seer Inc
SEER
+$14.5M
4
JBLU icon
JetBlue
JBLU
+$14.2M
5
AXSM icon
Axsome Therapeutics
AXSM
+$7.85M

Sector Composition

Rank Sector Weight
1 Healthcare 44.51%
2 Technology 13.21%
3 Financials 6.93%
4 Consumer Discretionary 6.6%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TKNO icon
76
Alpha Teknova
TKNO
$347M
$6.97M 0.44%
+293,581
New +$7.43M
DOW icon
77
Dow Inc
DOW
$21.2B
$6.96M 0.44%
110,000
– –
CRWD icon
78
CrowdStrike
CRWD
$218B
$6.92M 0.43%
110,084
+45,280
+70% +$2.44M
LRCX icon
79
Lam Research
LRCX
$390B
$6.88M 0.43%
105,800
-13,520
-11% -$853K
AMRC icon
80
Ameresco
AMRC
$1.36B
$6.74M 0.42%
107,401
-104,339
-49% -$5.62M
TCBI icon
81
Texas Capital Bancshares
TCBI
$4.32B
$6M 0.38%
94,512
+58,191
+160% +$3.92M
XYZ
82
Block Inc
XYZ
$47.5B
$5.68M 0.36%
23,310
+787
+3% +$183K
FITB
83
Fifth Third Bancorp
FITB
$51.8B
$5.35M 0.34%
140,000
-60,000
-30% -$2.4M
ASML icon
84
ASML
ASML
$669B
$5.15M 0.32%
7,453
-1,149
-13% -$758K
HOWL icon
85
Werewolf Therapeutics
HOWL
$19.3M
$5.14M 0.32%
+294,654
New +$4.04M
ABNB icon
86
Airbnb
ABNB
$107B
$5.13M 0.32%
33,473
+6,415
+24% +$1.01M
MAC icon
87
Macerich
MAC
$6.92B
$5.05M 0.32%
+276,882
New +$4.15M
PACW
88
DELISTED
PacWest Bancorp
PACW
$4.94M 0.31%
120,108
+28,678
+31% +$1.23M
COP icon
89
ConocoPhillips
COP
$141B
$4.87M 0.31%
+80,000
New +$4.46M
PYPL icon
90
PayPal
PYPL
$50.5B
$4.84M 0.3%
16,599
+32
+0.2% +$8.45K
DSGX icon
91
Descartes Systems
DSGX
$6.82B
$4.81M 0.3%
69,594
-6,970
-9% -$441K
TEAM icon
92
Atlassian
TEAM
$37.8B
$4.68M 0.29%
18,206
+2,900
+19% +$679K
APO icon
93
Apollo Global Management
APO
$73.4B
$4.67M 0.29%
+75,000
New +$4.16M
RRX icon
94
Regal Rexnord
RRX
$11.9B
$4.64M 0.29%
34,729
-10,792
-24% -$1.52M
BOOT icon
95
Boot Barn
BOOT
$4.95B
$4.46M 0.28%
+53,020
New +$3.89M
TSM icon
96
TSMC
TSM
$2.18T
$4.36M 0.27%
36,246
-4,888
-12% -$573K
GM icon
97
General Motors
GM
$76.8B
$4.33M 0.27%
73,173
– –
MTCH icon
98
Match Group
MTCH
$8.55B
$4.21M 0.26%
26,128
-3,222
-11% -$472K
ZION icon
99
Zions Bancorporation
ZION
$10.3B
$4.2M 0.26%
79,500
-45,500
-36% -$2.55M
FSS icon
100
Federal Signal
FSS
$7.83B
$4.18M 0.26%
+103,991
New +$4.27M
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Nicholas Investment Partners held 226 positions worth $1.59B, up 11% from $1.43B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nicholas Investment Partners withdrew a net $54.6M in Q2 2021, closing 27 positions and reducing 63 holdings. Its most notable exit was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Mirati Therapeutics, Inc. Common Stock worth $19.2M.

  • Nicholas Investment Partners's largest Q2 2021 buy was Mirati Therapeutics, Inc. Common Stock: 118,591 shares worth $19.2M.
  • Nicholas Investment Partners added most to Amyris Inc. in Q2 2021, an estimated $14.3M increase.
  • Nicholas Investment Partners's biggest Q2 2021 reduction was NovoCure, cutting an estimated $14.8M.
  • Nicholas Investment Partners fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 17% of its $1.59B portfolio in Q2 2021.
  • Nicholas Investment Partners opened 31 new positions and closed 27 in Q2 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.59B.

Based on Nicholas Investment Partners's 13F filing for Q2 2021, filed 10 Aug 2021.